21.11.2014 Views

primary prevention of coeliac disease - Associazione Italiana ...

primary prevention of coeliac disease - Associazione Italiana ...

primary prevention of coeliac disease - Associazione Italiana ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

THE BASIS OF COELIAC DISEASE<br />

5<br />

42<br />

healing . The calcium dependent transglutaminase activity <strong>of</strong> tTG catalyses selective<br />

43<br />

crosslinking or deamidation <strong>of</strong> protein-bound glutamine residues . In contrast to the<br />

non-enzymatically mediated deamidation that results in a near random deamidation <strong>of</strong><br />

the <strong>of</strong>ten numerous glutamine residues in gliadin peptides, tTG appears to carry out an<br />

ordered deamidation <strong>of</strong> some few specific glutamines. In all <strong>of</strong> the known major DQ2<br />

and DQ8 restricted gluten epitopes recognised by gut T cell <strong>of</strong> adult patients, there are<br />

36-37-44<br />

glutamic acid residues modified by tTG which is important for T cell recognition .<br />

Interestingly, the deamidation <strong>of</strong> glutamine residues that are not targeted by tTG (e.g.<br />

40-45<br />

by acid treatment) can be deleterious for T cell recognition . This suggests that<br />

deamidation in vivo is mediated by tTG. This idea is further supported by the results <strong>of</strong><br />

experiments where T cell lines have been established from biopsies challenged with a<br />

minimally deamidated gliadin antigen (chymotrypsin-digested). In all but one <strong>of</strong> 18<br />

adult patients, the established T cell lines only barely responded to the chymotrypsindigested<br />

gliadins, but efficiently recognized the in vitro tTG-treated variants <strong>of</strong> the<br />

46<br />

same gliadins .<br />

Normally we do not mount immune responses to edible proteins. Moreover,<br />

experimental animal models have demonstrated that oral administration <strong>of</strong> antigen<br />

47<br />

usually results in systemic hyporesponsiveness to the same antigen . This<br />

phenomenon, which is termed oral tolerance, is believed to occur because <strong>of</strong> active<br />

tolerization towards edible proteins. In keeping with this thinking, oral tolerance to<br />

gluten in CD patients may not have been established properly or is broken. Given the<br />

preferential intestinal T cell response to deamidated gluten fragments in CD patients, it<br />

may be that deamidation is involved in the perturbation <strong>of</strong> the oral gluten tolerance.<br />

Deamidation increases the binding affinity <strong>of</strong> gliadin peptides for DQ2 from poor but<br />

36-<br />

significant binders, to epitopes with reasonable, but by no means exceptional affinity<br />

44<br />

. The moderate binding affinity <strong>of</strong> these epitopes concurs with the finding that they do<br />

not carry optimal anchors in all the anchor positions. Interestingly, T cell clones specific<br />

for the DQ2-g-gliadin-I, DQ2-a-gliadin-I and DQ2-a-gliadin-II epitopes generally fail<br />

to recognise native peptides at higher concentrations that should compensate for their<br />

lower binding affinity for DQ2. Thus, concurrent with the increase in the binding<br />

affinity for DQ2 caused by deamidation <strong>of</strong> the gliadin peptide, there likely is a change in<br />

the conformation1<strong>of</strong> the gliadin/DQ2 complexes. Oral tolerance to antigens ingested in<br />

47<br />

high doses is usually established by T cell anergy or deletion . It is possible that T cells<br />

specific for native gluten sequences are usually anergised or deleted, and that phlogistic<br />

T cell responses are effectively mounted to novel gluten epitopes being created in an<br />

inflamed environment by the help <strong>of</strong> tTG.<br />

How many gluten T cell epitopes?<br />

There exist several epitopes in gluten that are recognized by small intestinal T cells<br />

35<br />

<strong>of</strong> CD patients . Recent results <strong>of</strong> the author's laboratory and the laboratory <strong>of</strong> Frits<br />

Koning in Leiden indicate that there may be more than ten distinct DQ2 restricted<br />

epitopes. The existence <strong>of</strong> multiple epitopes raises several interesting questions: are<br />

only some <strong>of</strong> the epitopes pathogenic and thereby relevant to explain the HLA<br />

association? Are responses towards some <strong>of</strong> the epitopes generated during the early<br />

phases <strong>of</strong> <strong>disease</strong> development, while the responses to others are a result <strong>of</strong> epitope

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!